These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2120080)

  • 41. NIH conference. Aldose reductase and complications of diabetes.
    Cogan DG; Kinoshita JH; Kador PF; Robison G; Datilis MB; Cobo LM; Kupfer C
    Ann Intern Med; 1984 Jul; 101(1):82-91. PubMed ID: 6203454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of the multiple forms of duck lens delta-crystallin with endogenous argininosuccinate lyase activity.
    Lee HJ; Lin CC; Chiou SH; Chang GG
    Arch Biochem Biophys; 1994 Oct; 314(1):31-8. PubMed ID: 7944404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Normalization of lens protein kinase Cgamma in galactosemic dogs by a novel aldose reductase inhibitor.
    Takemoto DJ; Harris R; Brightman A; McGill J; Hua D; Davidson H; Fenwick B; Wagner LM
    Vet Ophthalmol; 2004; 7(3):163-7. PubMed ID: 15091323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor.
    Robison WG; Kador PF; Kinoshita JH
    Science; 1983 Sep; 221(4616):1177-9. PubMed ID: 6612330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The glycation and cross-linking of isolated lens crystallins by ascorbic acid.
    Prabhakaram M; Ortwerth BJ
    Exp Eye Res; 1992 Sep; 55(3):451-9. PubMed ID: 1426076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
    Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crosslinking of human lens 9 kDa gammaD-crystallin fragment in vitro and in vivo.
    Srivastava OP; Srivastava K
    Mol Vis; 2003 Dec; 9():644-56. PubMed ID: 14685148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergism of sorbinil and normal diet on reversal of stage-II sugar cataract.
    Beyer-Mears A; Kelly K; Cruz E
    Pharmacology; 1985; 31(3):170-9. PubMed ID: 3931105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR; Moriarty RJ; Mayer JH
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-tryptophan fluorescence of crystallins from normal and cataractous human lenses.
    Bessems GJ; Keizer E; Wollensak J; Hoenders HJ
    Invest Ophthalmol Vis Sci; 1987 Jul; 28(7):1157-63. PubMed ID: 3596993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of streptozotocin-induced diabetes and aldose reductase inhibition with sorbinil, on left and right atrial function in the rat.
    Sellers DJ; Chess-Williams R
    J Pharm Pharmacol; 2000 Jun; 52(6):687-94. PubMed ID: 10875546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversal of proteinuria by sorbinil, an aldose reductase inhibitor in spontaneously diabetic (BB) rats.
    Beyer-Mears A; Murray FT; Del Val M; Cruz E; Sciadini M
    Pharmacology; 1988; 36(2):112-20. PubMed ID: 3127836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats.
    Mauer SM; Steffes MW; Azar S; Brown DM
    Diabetes; 1989 Jul; 38(7):839-46. PubMed ID: 2525493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A temporal and spatial study of the synthesis and degradation of water-soluble and insoluble proteins in galactosemic rat lenses.
    Williams EH; Chaplain TL; Meakem T
    Exp Eye Res; 1985 Oct; 41(4):475-86. PubMed ID: 4085577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The increase in lipid peroxidation in diabetic rat lens can be reversed by oral sorbinil.
    Yeh LA; Ashton MA
    Metabolism; 1990 Jun; 39(6):619-22. PubMed ID: 2112676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Time-dependent aspects of osmolyte changes in rat kidney, urine, blood and lens with sorbinil and galactose feeding.
    Edmands SD; Hughs KS; Lee SY; Meyer SD; Saari E; Yancey PH
    Kidney Int; 1995 Aug; 48(2):344-53. PubMed ID: 7564101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reversal of galactose cataract with Sorbinil in rats.
    Hu TS; Datiles M; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1983 May; 24(5):640-4. PubMed ID: 6841013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diuretic and natriuretic effects of sorbinil, an aldose reductase inhibitor.
    Springate JE; Feld LG; Van Liew JB; Fildes RD; Acara MA
    Pharmacol Res; 1991 Apr; 23(3):279-83. PubMed ID: 1906172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats.
    Yue DK; Hanwell MA; Satchell PM; Turtle JR
    Diabetes; 1982 Sep; 31(9):789-94. PubMed ID: 6819173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
    Bhatnagar A; Liu SQ; Das B; Ansari NH; Srivastava SK
    Biochem Pharmacol; 1990 Mar; 39(6):1115-24. PubMed ID: 2157439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.